Immunopathogenesis of HIV infection.
暂无分享,去创建一个
A. Fauci | G. Pantaleo | G Pantaleo | A S Fauci | A. Fauci
[1] S. Matsushita,et al. Antibody-mediated in vitro neutralization of human immunodeficiency virus type 1 abolishes infectivity for chimpanzees , 1990, Journal of virology.
[2] J. Genescà,et al. Clinical correlation and genetic polymorphism of the human immunodeficiency virus proviral DNA obtained after polymerase chain reaction amplification. , 1990, The Journal of infectious diseases.
[3] R. Rose,et al. The HIV core protein p24 inhibits interferon-gamma-induced increase of HLA-DR and cytochrome b heavy chain mRNA levels in the human monocyte-like cell line THP1. , 1991, Cellular immunology.
[4] D. Carrigan,et al. Suppression of human immunodeficiency virus type 1 replication by human herpesvirus-6. , 1990, The Journal of infectious diseases.
[5] M. Strand,et al. Inhibition of protein kinase C and anti-CD3-induced Ca2+ influx in Jurkat T cells by a synthetic peptide with sequence identity to HIV-1 gp41. , 1990, Journal of immunology.
[6] M. de Carli,et al. Ability of HIV to promote a TH1 to TH0 shift and to replicate preferentially in TH2 and TH0 cells. , 1994, Science.
[7] D. Ho. HIV-1 viraemia and influenza , 1992, The Lancet.
[8] M. Stevenson,et al. Integration is not necessary for expression of human immunodeficiency virus type 1 protein products , 1990, Journal of virology.
[9] A. Fauci,et al. Immunopathogenic mechanisms of HIV infection: cytokine induction of HIV expression. , 1990, Immunology today.
[10] P. Fultz,et al. HIV-infected humans, but not chimpanzees, have circulating cytotoxic T lymphocytes that lyse uninfected CD4+ cells. , 1990, Journal of immunology.
[11] A. Dalgleish,et al. Variable and conserved neutralization antigens of human immunodeficiency virus , 1986, Nature.
[12] S. Arya,et al. Identification of RANTES, MIP-1α, and MIP-1β as the Major HIV-Suppressive Factors Produced by CD8+ T Cells , 1995, Science.
[13] D. Baltimore,et al. Lipopolysaccharide is a potent monocyte/macrophage-specific stimulator of human immunodeficiency virus type 1 expression , 1990, The Journal of experimental medicine.
[14] D. Ho,et al. Virologic and immunologic characterization of long-term survivors of human immunodeficiency virus type 1 infection. , 1995, The New England journal of medicine.
[15] D. Giulian,et al. Secretion of neurotoxins by mononuclear phagocytes infected with HIV-1 , 1990, Science.
[16] Q. Myrvik,et al. Human immunodeficiency virus type 1 (HIV-1) and herpes simplex virus type 2 (HSV-2) can coinfect and simultaneously replicate in the same human CD4+ cell: effect of coinfection on infectious HSV-2 and HIV-1 replication. , 1990, AIDS research and human retroviruses.
[17] Mauro Vaccarezza,et al. Role of Lymphoid Organs in the Pathogenesis of Human Immunodeficiency Virus (HIV) Infection , 1994, Immunological reviews.
[18] J. Phair. Keynote address: variations in the natural history of HIV infection. , 1994, AIDS research and human retroviruses.
[19] F. Miedema,et al. Changes in cytokine secretion patterns of CD4+ T-cell clones in human immunodeficiency virus infection. , 1994, Blood.
[20] Huisman,et al. Differential syncytium-inducing capacity of human immunodeficiency virus isolates: frequent detection of syncytium-inducing isolates in patients with acquired immunodeficiency syndrome (AIDS) and AIDS-related complex , 1988, Journal of virology.
[21] J. Justement,et al. Preferential infection of CD4+ memory T cells by human immunodeficiency virus type 1: evidence for a role in the selective T-cell functional defects observed in infected individuals. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[22] A. Fauci,et al. The effect of cytokines and pharmacologic agents on chronic HIV infection. , 1992, AIDS research and human retroviruses.
[23] A. Fauci,et al. Lack of evidence for the dichotomy of TH1 and TH2 predominance in HIV-infected individuals. , 1994, Science.
[24] A. Perelson,et al. Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection , 1995, Nature.
[25] R. Gallo,et al. Detection of lymphocytes expressing human T-lymphotropic virus type III in lymph nodes and peripheral blood from infected individuals by in situ hybridization. , 1986, Proceedings of the National Academy of Sciences of the United States of America.
[26] M. Dietrich,et al. ALTERED FOLLICULAR DENDRITIC CELLS AND VIRUS-LIKE PARTICLES IN AIDS AND AIDS-RELATED LYMPHADENOPATHY , 1985, The Lancet.
[27] C V Jongeneel,et al. Single-cell PCR analysis of TCR repertoires selected by antigen in vivo: a high magnitude CD8 response is comprised of very few clones. , 1996, Immunity.
[28] Luc Montagnier,et al. T-lymphocyte T4 molecule behaves as the receptor for human retrovirus LAV , 1984, Nature.
[29] Ashley T. Haase,et al. Massive covert infection of helper T lymphocytes and macrophages by HIV during the incubation period of AIDS , 1993, Nature.
[30] P. Earl,et al. Antigenic implications of human immunodeficiency virus type 1 envelope quaternary structure: oligomer-specific and -sensitive monoclonal antibodies. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[31] R. V. van Lier,et al. AIDS pathogenesis: a dynamic interaction between HIV and the immune system. , 1990, Immunology today.
[32] F. de Wolf,et al. Biphasic rate of CD4+ cell count decline during progression to AIDS correlates with HIV‐1 phenotype , 1992, AIDS.
[33] M. Baseler,et al. Integrated proviral human immunodeficiency virus type 1 is present in CD4+ peripheral blood lymphocytes in healthy seropositive individuals , 1989, Journal of virology.
[34] Rolf M. Zinkernagel,et al. Immunology Taught by Viruses , 1996, Science.
[35] S E Macatonia,et al. Dendritic cell infection, depletion and dysfunction in HIV-infected individuals. , 1990, Immunology.
[36] A. Fauci,et al. Multifactorial nature of human immunodeficiency virus disease: implications for therapy. , 1993, Science.
[37] Jerome A. Zack,et al. HIV-1 entry into quiescent primary lymphocytes: Molecular analysis reveals a labile, latent viral structure , 1990, Cell.
[38] J. Margolick,et al. Studies in subjects with long-term nonprogressive human immunodeficiency virus infection. , 1995, The New England journal of medicine.
[39] A. Fauci,et al. Interferon-alpha but not AZT suppresses HIV expression in chronically infected cell lines. , 1989, Science.
[40] J. Levy,et al. Serum enhancement of human immunodeficiency virus (HIV) infection correlates with disease in HIV-infected individuals , 1990, Journal of virology.
[41] T. Waldmann,et al. Qualitative analysis of immune function in patients with the acquired immunodeficiency syndrome. Evidence for a selective defect in soluble antigen recognition. , 1985, The New England journal of medicine.
[42] S. Zolla-Pazner,et al. Synergistic neutralization of human immunodeficiency virus type 1 by combinations of human monoclonal antibodies , 1994, Journal of virology.
[43] D. Montefiori,et al. Antibody-dependent enhancement of human immunodeficiency virus type 1 (HIV-1) infection in vitro by serum from HIV-1-infected and passively immunized chimpanzees. , 1989, Proceedings of the National Academy of Sciences of the United States of America.
[44] C. Kunsch,et al. Infection of human fetal dorsal root ganglion glial cells with human immunodeficiency virus type 1 involves an entry mechanism independent of the CD4 T4A epitope , 1989, Journal of virology.
[45] P. Easterbrook. Non-progression in HIV infection. , 1994, AIDS.
[46] C. Chang,et al. Cytomegalovirus enhances lysis of HIV‐infected T lymphoblasts , 1989, International journal of cancer.
[47] M P Dempsey,et al. Quiescent T lymphocytes as an inducible virus reservoir in HIV-1 infection. , 1991, Science.
[48] A. Fauci,et al. Suppression of human immunodeficiency virus expression in chronically infected monocytic cells by glutathione, glutathione ester, and N-acetylcysteine. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[49] J. Moore,et al. Development of the anti-gp120 antibody response during seroconversion to human immunodeficiency virus type 1 , 1994, Journal of virology.
[50] I. Keet,et al. Prognostic Value of HIV-1 Syncytium-Inducing Phenotype for Rate of CD4+ Cell Depletion and Progression to AIDS , 1993, Annals of Internal Medicine.
[51] P. Shapshak,et al. Demonstration of human immunodeficiency virus in renal epithelium in HIV-associated nephropathy. , 1989, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.
[52] S. J. Clark,et al. High levels of HIV-1 in plasma during all stages of infection determined by competitive PCR. , 1993, Science.
[53] J. Berzofsky,et al. Cytokine interactions in human immunodeficiency virus-infected individuals: roles of interleukin (IL)-2, IL-12, and IL-15 , 1995, The Journal of experimental medicine.
[54] A. Fauci,et al. Heat shock induction of HIV production from chronically infected promonocytic and T cell lines. , 1990, Journal of immunology.
[55] A. Nel,et al. HIV inhibits the early steps of lymphocyte activation, including initiation of inositol phospholipid metabolism. , 1990, Journal of immunology.
[56] P. Klenerman,et al. Cytotoxic T Lymphocyte Lysis Inhibited by Viable HIV Mutants , 1995, Science.
[57] John L. Sullivan,et al. Absence of intact nef sequences in a long-term survivor with nonprogressive HIV-1 infection , 1995 .
[58] F. Miedema,et al. Functional and phenotypic evidence for a selective loss of memory T cells in asymptomatic human immunodeficiency virus-infected men. , 1990, The Journal of clinical investigation.
[59] G. Pantaleo,et al. Effect of anti‐V3 antibodies on cell‐free and cell‐to‐cell human immunodeficiency virus transmission , 1995, European journal of immunology.
[60] Anthony S. Fauci,et al. Toward an Understanding of the Correlates of Protective Immunity to HIV Infection , 1996, Science.
[61] M. Gonda,et al. Negative regulation of human immune deficiency virus replication in monocytes. Distinctions between restricted and latent expression in THP- 1 cells , 1990, The Journal of experimental medicine.
[62] Y. Masuho,et al. Human monoclonal antibodies to the human immunodeficiency virus type 1 (HIV-1) transmembrane glycoprotein gp41 enhance HIV-1 infection in vitro. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[63] D. Richman,et al. Human immunodeficiency virus-1 infection of macrophages in vitro neither induces tumor necrosis factor (TNF)/cachectin gene expression nor alters TNF/cachectin induction by lipopolysaccharide. , 1990, The Journal of clinical investigation.
[64] M. Clerici,et al. A TH1-->TH2 switch is a critical step in the etiology of HIV infection. , 1993, Immunology today.
[65] G. F. Burton,et al. Follicular dendritic cells and human immunodeficiency virus infectivity , 1995, Nature.
[66] M. Roederer,et al. Cytokine-stimulated human immunodeficiency virus replication is inhibited by N-acetyl-L-cysteine. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[67] O. Strannegard,et al. Zidovudine in the management of primary HIV‐1 infection , 1991, AIDS.
[68] J. Coffin,et al. HIV population dynamics in vivo: implications for genetic variation, pathogenesis, and therapy , 1995, Science.
[69] S. Buchbinder,et al. Long‐term HIV‐1 infection without immunologic progression , 1994, AIDS.
[70] A. Fauci,et al. New concepts in the immunopathogenesis of HIV infection. , 1995, Annual review of immunology.
[71] U. Sharma,et al. Naturally occurring HIV-1 isolates with differences in replicative capacity are distinguished by in situ hybridization of infected cells. , 1990, AIDS research and human retroviruses.
[72] M. Greaves,et al. The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus , 1984, Nature.
[73] A. Fauci,et al. Tracking HIV during disease progression. , 1994, Current opinion in immunology.
[74] A. Fauci,et al. Immunopathogenesis of the acquired immunodeficiency syndrome. , 1986, Annals of internal medicine.
[75] J K Nicholson,et al. Binding of HTLV-III/LAV to T4+ T cells by a complex of the 110K viral protein and the T4 molecule. , 1986, Science.
[76] Q. Sattentau,et al. Human immunodeficiency virus type 1 neutralization is determined by epitope exposure on the gp120 oligomer , 1995, The Journal of experimental medicine.
[77] R. Gallo,et al. Restricted neutralization of divergent human T-lymphotropic virus type III isolates by antibodies to the major envelope glycoprotein. , 1986, Proceedings of the National Academy of Sciences of the United States of America.
[78] T. A. Hagan,et al. Detection , Isolation , and Continuous Production of Cytopathic Retroviruses ( HTLV-III ) from Patients with AIDS and Pre-AIDS , 2022 .
[79] M. Robert-Guroff,et al. HTLV-III-neutralizing antibodies in patients with AIDS and AIDS-related complex , 1985, Nature.
[80] C. Cavard,et al. In vivo activation by ultraviolet rays of the human immunodeficiency virus type 1 long terminal repeat. , 1990, The Journal of clinical investigation.
[81] W. Greene,et al. HIV-1, HTLV-1 and normal T-cell growth: transcriptional strategies and surprises. , 1989, Immunology today.
[82] D. Ho,et al. CD4-independent, productive human immunodeficiency virus type 1 infection of hepatoma cell lines in vitro , 1990, Journal of virology.
[83] A. Fauci,et al. Activated B lymphocytes from human immunodeficiency virus-infected individuals induce virus expression in infected T cells and a promonocytic cell line, U1 , 1991, The Journal of experimental medicine.
[84] C. Debouck,et al. Activation of human immunodeficiency virus type 1 by DNA damage in human cells , 1988, Nature.
[85] Fauci As. AIDS: immunopathogenic mechanisms and research strategies. , 1987 .
[86] C. Kufta,et al. Specific tropism of HIV-1 for microglial cells in primary human brain cultures. , 1990, Science.
[87] D. Littman,et al. Pseudotyping with human T-cell leukemia virus type I broadens the human immunodeficiency virus host range , 1991, Journal of virology.
[88] Charles R. M. Bangham,et al. Human immunodeficiency virus genetic variation that can escape cytotoxic T cell recognition , 1991, Nature.
[89] D. Montefiori,et al. V3-specific neutralizing antibodies in sera from HIV-1 gp160-immunized volunteers block virus fusion and act synergistically with human monoclonal antibody to the conformation-dependent CD4 binding site of gp120. NIH-NIAID AIDS Vaccine Clinical Trials Network. , 1993, The Journal of clinical investigation.
[90] S. Allen,et al. Co-infection and synergy of human immunodeficiency virus-1 and herpes simplex virus-1 , 1994, The Lancet.
[91] D. Scadden,et al. Human immunodeficiency virus does not induce interleukin-1, interleukin-6, or tumor necrosis factor in mononuclear cells , 1990, Journal of virology.
[92] J. Armstrong,et al. Retroviral infection of accessory cells and the immunological paradox in AIDS. , 1985, Immunology today.
[93] Anthony S. Fauci,et al. HIV infection is active and progressive in lymphoid tissue during the clinically latent stage of disease , 1993, Nature.
[94] K. Metzner,et al. HIV suppression by interleukin-16 , 1995, Nature.
[95] R. Cheynier,et al. Long-term cultures of HTLV-III--infected T cells: a model of cytopathology of T-cell depletion in AIDS. , 1986, Science.
[96] B. Franza,et al. Stimulation of the human immunodeficiency virus type 1 enhancer by the human T-cell leukemia virus type I tax gene product involves the action of inducible cellular proteins , 1989, Journal of virology.
[97] J. Berzofsky,et al. Interleukin-2 production used to detect antigenic peptide recognition by T-helper lymphocytes from asymptomatic HIV-seropositive individuals , 1989, Nature.
[98] Soluble CD4 blocks the infectivity of diverse strains of HIV and SIV for T cells and monocytes but not for brain and muscle cells. , 1990, Disease markers.
[99] R. Kettmann,et al. A specific defect in CD3 gamma-chain gene transcription results in loss of T-cell receptor/CD3 expression late after human immunodeficiency virus infection of a CD4+ T-cell line. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[100] D. Richman,et al. Reinfection results in accumulation of unintegrated viral DNA in cytopathic and persistent human immunodeficiency virus type 1 infection of CEM cells , 1990, The Journal of experimental medicine.
[101] Karen L. Elkins,et al. Neuronal cell killing by the envelope protein of HIV and its prevention by vasoactive intestinal peptide , 1988, Nature.
[102] Ying Sun,et al. Replicative function and neutralization sensitivity of envelope glycoproteins from primary and T-cell line-passaged human immunodeficiency virus type 1 isolates , 1995, Journal of virology.
[103] L. Montagnier,et al. Early stages of simian immunodeficiency virus infection in lymph nodes. Evidence for high viral load and successive populations of target cells. , 1994, The American journal of pathology.
[104] A. Fauci,et al. The human immunodeficiency virus: infectivity and mechanisms of pathogenesis. , 1988, Science.
[105] M. McGrath,et al. Human immunodeficiency virus-infected macrophages produce soluble factors that cause histological and neurochemical alterations in cultured human brains. , 1991, The Journal of clinical investigation.
[106] G. Pantaleo,et al. Decreased human immunodeficiency virus type 1 plasma viremia during antiretroviral therapy reflects downregulation of viral replication in lymphoid tissue. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[107] S. J. Clark,et al. High titers of cytopathic virus in plasma of patients with symptomatic primary HIV-1 infection. , 1991, The New England journal of medicine.
[108] A. Fauci,et al. Kinetics of human immunodeficiency virus type 1 (HIV-1) DNA and RNA synthesis during primary HIV-1 infection. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[109] J. Levy,et al. Replication of HIV-1 in a wide variety of animal cells following phenotypic mixing with murine retroviruses. , 1990, Virology.
[110] D. Ho,et al. Transient high levels of viremia in patients with primary human immunodeficiency virus type 1 infection. , 1991, The New England journal of medicine.
[111] A. Fauci,et al. The immunopathogenesis of human immunodeficiency virus infection. , 1993, The New England journal of medicine.
[112] P. Berman,et al. Cryptic nature of envelope V3 region epitopes protects primary monocytotropic human immunodeficiency virus type 1 from antibody neutralization , 1994, Journal of virology.
[113] M. Champe,et al. Protection of chimpanzees from infection by HIV-1 after vaccination with recombinant glycoprotein gp120 but not gp160 , 1990, Nature.
[114] J. Strominger,et al. Interaction between CD4 and class II MHC molecules mediates cell adhesion , 1987, Nature.
[115] J. Goudsmit,et al. Heat-shock induction of the human immunodeficiency virus long terminal repeat. , 1988, The Journal of general virology.
[116] J. Justement,et al. Tumor necrosis factor alpha functions in an autocrine manner in the induction of human immunodeficiency virus expression. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[117] Martin A. Nowak,et al. Viral dynamics in human immunodeficiency virus type 1 infection , 1995, Nature.
[118] A. Fauci,et al. Induction of expression of HIV in latently or chronically infected cells. , 1989, AIDS research and human retroviruses.
[119] H. Stein,et al. Follicular dendritic cells are a major reservoir for human immunodeficiency virus type 1 in lymphoid tissues facilitating infection of CD4+ T-helper cells. , 1992, The American journal of pathology.
[120] T. Merigan,et al. Recombinant HIV structural proteins detect specific cellular immunity in vitro in infected individuals. , 1988, AIDS research and human retroviruses.
[121] D. Abrams,et al. Persistent diffuse lymphadenopathy in homosexual men: endpoint or prodrome? , 1984, Annals of internal medicine.
[122] M. Baseler,et al. Increasing viral burden in CD4+ T cells from patients with human immunodeficiency virus (HIV) infection reflects rapidly progressive immunosuppression and clinical disease. , 1990, Annals of internal medicine.
[123] G. Nabel,et al. An inducible transcription factor activates expression of human immunodeficiency virus in T cells , 1990, Nature.
[124] C. Cheng‐Mayer,et al. Identification of human immunodeficiency virus subtypes with distinct patterns of sensitivity to serum neutralization. , 1988, Proceedings of the National Academy of Sciences of the United States of America.
[125] Robin A. Weiss,et al. Neutralization of human T-lymphotropic virus type III by sera of AIDS and AIDS-risk patients , 1985, Nature.
[126] E. Gelmann,et al. The Acquired Immunodeficiency Syndrome: An Update , 1985 .
[127] C H Fox,et al. The reservoir for HIV-1 in human peripheral blood is a T cell that maintains expression of CD4. , 1989, Science.
[128] E. Vittinghoff,et al. The characterization of non‐progressors: long‐term HIV‐1 infection with stable CD4+ T‐cell levels , 1993, AIDS.
[129] A. Collier,et al. Plasma viremia in human immunodeficiency virus infection. , 1989, The New England journal of medicine.
[130] J. Justement,et al. Transforming growth factor beta suppresses human immunodeficiency virus expression and replication in infected cells of the monocyte/macrophage lineage , 1991, The Journal of experimental medicine.
[131] S. Buchbinder,et al. Long-term human immunodeficiency virus infection in asymptomatic homosexual and bisexual men with normal CD4+ lymphocyte counts: immunologic and virologic characteristics. , 1991, The Journal of infectious diseases.
[132] H. Schuitemaker,et al. Biological phenotype of human immunodeficiency virus type 1 clones at different stages of infection: progression of disease is associated with a shift from monocytotropic to T-cell-tropic virus population , 1992, Journal of virology.
[133] G. Shaw,et al. Virus-specific CD8+ cytotoxic T-lymphocyte activity associated with control of viremia in primary human immunodeficiency virus type 1 infection , 1994, Journal of virology.
[134] J. Levy,et al. Rapid CD8+ Cell Anti-HIV Activity Correlates with the Clinical State of the Infected Individual , 2003 .
[135] A. Fauci,et al. The role of lymphoid organs in the pathogenesis of HIV infection. , 1993, Seminars in immunology.
[136] K. Sell,et al. Characterization of a continuous T-cell line susceptible to the cytopathic effects of the acquired immunodeficiency syndrome (AIDS)-associated retrovirus. , 1985, Proceedings of the National Academy of Sciences of the United States of America.
[137] A. Fauci,et al. The immunopathogenesis of HIV infection. , 1989, Advances in immunology.
[138] A. Osterhaus,et al. Impairment of in vitro immune responses occurs within 3 months after HIV-1 seroconversion. , 1990, AIDS.
[139] J. Levy,et al. Isolation of lymphocytopathic retroviruses from San Francisco patients with AIDS. , 1984, Science.
[140] J. Habeshaw,et al. AIDS pathogenesis: HIV envelope and its interaction with cell proteins. , 1990, Immunology today.
[141] M. Denis,et al. Mycobacterium avium infection in HIV‐1‐infected subjects increases monokine secretion and is associated with enhanced viral load and diminished immune response to viral antigens , 1994, Clinical and experimental immunology.
[142] A. Fauci,et al. Viral antigen stimulation of the production of human monokines capable of regulating HIV1 expression. , 1989, Journal of immunology.
[143] Persephone Borrow,et al. Major expansion of CD8+ T cells with a predominant Vβ usage during the primary immune response to HIV , 1994, Nature.
[144] M. Gale,et al. Simian immunodeficiency virus is restricted to a subset of blood CD4+ lymphocytes that includes memory cells. , 1990, Journal of immunology.
[145] M. Gurney,et al. Functional interaction and partial homology between human immunodeficiency virus and neuroleukin. , 1987, Science.
[146] P. Herrlich,et al. UV-induced transcription from the human immunodeficiency virus type 1 (HIV-1) long terminal repeat and UV-induced secretion of an extracellular factor that induces HIV-1 transcription in nonirradiated cells , 1989, Journal of virology.
[147] J. Hoxie,et al. Persistent noncytopathic infection of normal human T lymphocytes with AIDS-associated retrovirus. , 1985, Science.
[148] P. Simmonds,et al. Human immunodeficiency virus-infected individuals contain provirus in small numbers of peripheral mononuclear cells and at low copy numbers , 1990, Journal of virology.
[149] S. Lipton,et al. HIV-1 coat protein neurotoxicity prevented by calcium channel antagonists. , 1990, Science.
[150] J. Levy,et al. Detection of HIV in enterochromaffin cells in the rectal mucosa of an AIDS patient. , 1989, The American journal of gastroenterology.
[151] W. Paul,et al. Interleukin 4 is important in protective immunity to a gastrointestinal nematode infection in mice. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[152] R. Steinman,et al. Latent HIV-1 infection in enriched populations of blood monocytes and T cells from seropositive patients. , 1991, The Journal of clinical investigation.
[153] F. Brun-Vézinet,et al. Isolation of lymphadenopathy-associated virus (LAV) and detection of LAV antibodies from US patients with AIDS. , 1985, JAMA.
[154] R. Kurth,et al. Productive infection of both CD4+ and CD4- human cell lines with HIV-1, HIV-2 and SIVagm. , 1990, AIDS.
[155] J. Laurence,et al. Molecular interactions among herpesviruses and human immunodeficiency viruses. , 1990, The Journal of infectious diseases.
[156] K. Nakamura,et al. Intracellular distribution of the envelope glycoprotein of human immunodeficiency virus and its role in the production of cytopathic effect in CD4+ and CD4- human cell lines , 1990, Journal of virology.
[157] J. Hoxie,et al. Alterations in T4 (CD4) protein and mRNA synthesis in cells infected with HIV. , 1986, Science.
[158] E. Jaffe,et al. Infection and replication of HIV-1 in purified progenitor cells of normal human bone marrow , 1988, Science.
[159] J. Mellors,et al. Tumor necrosis factor-alpha/cachectin enhances human immunodeficiency virus type 1 replication in primary macrophages. , 1991, The Journal of infectious diseases.
[160] B. Autran,et al. A Th0/Th2-like function of CD4+CD7- T helper cells from normal donors and HIV-infected patients. , 1995, Journal of immunology.
[161] E. Tschachler,et al. Productive dual infection of human CD4+ T lymphocytes by HIV-1 and HHV-6 , 1989, Nature.
[162] F. Chisari,et al. Intracellular inactivation of the hepatitis B virus by cytotoxic T lymphocytes. , 1996, Immunity.
[163] S. Buus,et al. The T-cell accessory molecule CD4 recognizes a monomorphic determinant on isolated Ia. , 1988, Proceedings of the National Academy of Sciences of the United States of America.
[164] D. Ho,et al. Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome , 1994, Journal of virology.
[165] J. Groopman,et al. Infection of nonlymphoid cells by human immunodeficiency virus type 1 or type 2 , 1990, Journal of virology.
[166] M. McElrath,et al. Mononuclear phagocytes of blood and bone marrow: comparative roles as viral reservoirs in human immunodeficiency virus type 1 infections. , 1989, Proceedings of the National Academy of Sciences of the United States of America.
[167] J. Lifson,et al. Non-cytolytic CD8 T-cell anti-HIV responses in primary HIV-1 infection , 1994, The Lancet.
[168] A. Fauci,et al. Lymphoid organs function as major reservoirs for human immunodeficiency virus. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[169] Albrecht,et al. The herpes simplex virus immediate-early protein, ICP4, is required to potentiate replication of human immunodeficiency virus in CD4+ lymphocytes , 1989, Journal of virology.
[170] T. Chou,et al. Synergistic neutralization of HIV-1 by human monoclonal antibodies against the V3 loop and the CD4-binding site of gp120. , 1992, AIDS research and human retroviruses.
[171] A. Fauci,et al. Induction of expression of human immunodeficiency virus in a chronically infected promonocytic cell line by ultraviolet irradiation. , 1989, AIDS research and human retroviruses.
[172] J. Levy,et al. HIV pathogenesis and long-term survival. , 1993, AIDS.
[173] Z. Toossi,et al. Activation of latent HIV-1 by Mycobacterium tuberculosis and its purified protein derivative in alveolar macrophages from HIV-infected individuals in vitro. , 1997, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.
[174] Quantitation of human immunodeficiency virus type 1 in the blood of infected persons. , 1990, Disease markers.
[175] C. Fox,et al. Lymphoid germinal centers are reservoirs of human immunodeficiency virus type 1 RNA. , 1991, The Journal of infectious diseases.
[176] J. Justement,et al. Interleukin 6 induces human immunodeficiency virus expression in infected monocytic cells alone and in synergy with tumor necrosis factor alpha by transcriptional and post-transcriptional mechanisms , 1990, The Journal of experimental medicine.
[177] J. McKeating,et al. Synergistic interaction between ligands binding to the CD4 binding site and V3 domain of human immunodeficiency virus type I gpl20 , 1992 .
[178] B. Haynes,et al. Evidence for susceptibility of intrathymic T-cell precursors and their progeny carrying T-cell antigen receptor phenotypes TCR alpha beta + and TCR gamma delta + to human immunodeficiency virus infection: a mechanism for CD4+ (T4) lymphocyte depletion. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[179] D. Israëł-Biet,et al. Human immunodeficiency virus production by alveolar lymphocytes is increased during Pneumocystis carinii pneumonia. , 1993, The American review of respiratory disease.
[180] J. Sidtis,et al. The brain in AIDS: central nervous system HIV-1 infection and AIDS dementia complex. , 1988, Science.
[181] W. Rom,et al. Mycobacterium tuberculosis enhances human immunodeficiency virus-1 replication by transcriptional activation at the long terminal repeat. , 1995, The Journal of clinical investigation.
[182] B. Autran,et al. Human immunodeficiency virus-1 glycoproteins gp120 and gp160 specifically inhibit the CD3/T cell-antigen receptor phosphoinositide transduction pathway. , 1990, The Journal of clinical investigation.
[183] M. Kieny,et al. Immunization of chimpanzees confers protection against challenge with human immunodeficiency virus. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[184] N. Brousse,et al. Production of interleukins in human immunodeficiency virus-1-replicating lymph nodes. , 1990, The Journal of clinical investigation.
[185] Lange,et al. Evidence for a role of virulent human immunodeficiency virus (HIV) variants in the pathogenesis of acquired immunodeficiency syndrome: studies on sequential HIV isolates , 1989, Journal of virology.
[186] H. Lyerly,et al. HIV-1 GP120-mediated immune suppression and lymphocyte destruction in the absence of viral infection. , 1989, Journal of immunology.
[187] C. June,et al. No T-cell tyrosine protein kinase signalling or calcium mobilization after CD4 association with HIV-1 or HIV-1 gp120 , 1990, Nature.
[188] D. Montefiori,et al. Immunopathogenic events in acute infection of rhesus monkeys with simian immunodeficiency virus of macaques , 1994, Journal of virology.
[189] J. Convit,et al. Differing lymphokine profiles of functional subsets of human CD4 and CD8 T cell clones. , 1991, Science.